Welcome to the all-new Vetlearn

  • What’s new on Vetlearn?
  • The latest issues of Compendium and
    Veterinary Technician
  • New CE articles for veterinarians and technicians
  • Expert advice on practice management
  • Care guides on more than 400 subjects
    to give to your clients
  • And more!

To access Vetlearn, you must first sign in or register.

registernow

Become a Member

Veterinarian Technician December 2009 (Vol 30, No 12)

Insulin Receives FDA Approval

    ST. JOSEPH, MO — Boehringer Ingelheim Vetmedica Inc. (BIVI) has announced that ProZinc (protamine zinc recombinant human insulin) has been approved for veterinary use by the FDA. ProZinc is an aqueous protamine zinc (PZI) suspension of recombinant human insulin that is used to reduce hyperglycemia in cats with diabetes mellitus.

    According to Kurt Peterson, DVM, technical veterinarian with BIVI, ProZinc is the first recombinant human PZI insulin available for the management of feline diabetes mellitus. "Extensive research has demonstrated that ProZinc is safe and effective for controlling hyperglycemia in newly diagnosed cats and diabetic cats that have not responded well to previous treatment therapies.1"

    In addition, Peterson said the research shows that ProZinc provides consistent absorption with long duration of action, which results in consistent and predictable blood glucose control in diabetic cats.1

    "Because ProZinc is a protamine zinc recombinant human insulin, it offers some key advantages. First, recombinant technology is not subject to the raw material sourcing challenges seen with animal-source insulin products. Second, the protamine and zinc formulation of ProZinc provides a long duration of effect."

    Practitioners and cat owners who have used PZI-VET in the past should find this product to be comparable in potency, onset, and duration of glycemic control.2

    ProZinc should be administered with a U-40 insulin syringe and has an initial recommended dose range of 0.1-0.3 IU insulin/lb of body weight every 12 hours. ProZinc will be available for sale to veterinarians beginning Nov. 16, 2009. Veterinarians should contact their distributor or BIVI representative for more details and product availability. For more information, visit www.ProZinc.us.

    1. Nelson RW, Henley K, Cole C. Field Safety and Efficacy of PZIR for Treatment of Diabetes Mellitus in Cats. JVIM. 2009;23:787-793.

    2. Norsworthy GD, Lynn R, Cole C. Preliminary Study of Protamine Zinc Recombinant Insulin for the Treatment of Diabetes Mellitus in Cats. Vet Ther. 2009;10:24-28.

    References »

    NEXT: Let Your Voice Be Heard

    didyouknow

    Did you know... Because chemotherapeutic agents consistently suppress hematopoiesis, their administration should be monitored with periodic complete blood counts.Read More

    These Care Guides are written to help your clients understand common conditions. They are formatted to print and give to your clients for their information.

    Stay on top of all our latest content — sign up for the Vetlearn newsletters.
    • More
    Subscribe